These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2551560)

  • 1. Comparison of intravenous dilevalol with placebo in moderate hypertension.
    Winer N; Blasucci DJ; Medakovic M
    Clin Pharmacol Ther; 1989 Oct; 46(4):445-50. PubMed ID: 2551560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter comparison of dilevalol to placebo in patients with mild hypertension.
    Frishman WH; Schoenberger JA; Gorwit JI; Bedsole GD; Cubbon J; Poland MP
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):295S-299S. PubMed ID: 3046631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dilevalol compared with propranolol and placebo for systemic hypertension.
    Schoenberger JA; Frishman WH; Wallin JD; Gorwit J; Davidov ME; Michelson EL; Bedsole GD; Cubbon J; Poland MP
    Am J Cardiol; 1989 Jun; 63(19):45I-49I. PubMed ID: 2658529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and biological evaluation of dilevalol vasodilating properties in mild to moderate hypertension.
    Drici MD; Candito M; Ferrari E; Jacomet Y; Morand P; Lapalus P
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):361-5. PubMed ID: 1937998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety and efficacy of once-daily dilevalol in patients with mild hypertension: a placebo-controlled study.
    Soberman J; Greenberg S; Frishman W
    J Clin Hypertens; 1987 Sep; 3(3):271-7. PubMed ID: 3312501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
    Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
    Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly.
    Clifton GG; Cook ME; Poland M; Wallin JD
    J Clin Pharmacol; 1989 Jul; 29(7):603-8. PubMed ID: 2760254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and humoral effects of intravenous dilevalol in patients with moderate hypertension.
    Grossman E; Messerli FH; Oren S; MacPhee AA
    Am J Cardiol; 1989 Jun; 63(19):34I-37I. PubMed ID: 2524958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of dilevalol and placebo in the management of isolated systolic hypertension using ambulatory monitoring.
    Silagy CA; McNeil JJ; Farish S; McGrath BP
    Br J Clin Pharmacol; 1990 Nov; 30(5):657-64. PubMed ID: 2271366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter double-blind study of the efficacy and safety of once and twice daily dilevalol compared to propranolol.
    Schoenberger JA; Wallin JD; Gorwit JI; Davidov ME; Michelson EL; Poland MP; Frishman WH
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):840-6. PubMed ID: 2686711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilevalol in severe hypertension. A multicenter trial of bolus intravenous dosing.
    Wallin JD; Cook ME; Fletcher E; Holtzman JL; Winer N; Gavras H; Grim CE; Ramanathan KB; Vidt DG; Johnson BF
    Arch Intern Med; 1989 Dec; 149(12):2655-61. PubMed ID: 2688585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dilevalol and enalapril administered once daily for mild hypertension.
    Rodriguez-Saavedra M; Zannad FM; Guerrero-Sierra J; Sack DW; Renaud H; Guiducci U; Edwards LD
    Am J Cardiol; 1989 Jun; 63(19):50I-53I. PubMed ID: 2543201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hormonal and renal effects of oral dilevalol in normal men.
    Whitworth JA; Gordon D; Harpley R; Yeung S; Phillips P
    Clin Exp Pharmacol Physiol; 1989 Jan; 16(1):59-63. PubMed ID: 2523264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
    Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
    Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous dilevalol in the treatment of severe hypertension.
    Bursztyn M; Gavras I; Blasucci DJ; Gavras H
    J Cardiovasc Pharmacol; 1989 May; 13(5):799-802. PubMed ID: 2472530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive activity and duration of action of dilevalol in hypertensive patients at rest and during exercise. A comparison with captopril.
    Fogari R; Poletti L; Tettamanti F; Cesana B; Savonitto S
    G Ital Cardiol; 1990 Apr; 20(4):309-15. PubMed ID: 2197158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Eur J Clin Pharmacol; 1990; 38(3):305-7. PubMed ID: 2187701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dilevalol: a selective beta-2 adrenergic agonist vasodilator with beta adrenergic blocking activity.
    Wallin JD; Frishman WH
    J Clin Pharmacol; 1989 Dec; 29(12):1057-68. PubMed ID: 2693499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise.
    Bellissant E; Annane D; Thuillez C; Giudicelli JF
    Eur J Clin Pharmacol; 1994; 47(1):39-47. PubMed ID: 7988622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.